• 1
    Herzog R, Arruda VR, Fischer TH, Read MS, Nichols TC, High KA. Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill Colony. Thromb Haemost 2000; 84: 3524.
  • 2
    Wright AE. On a method of determining the conditions of blood coagulability for clinical and experimental purposes, and on the effect of the administration of calcium salts in haemohpilia and actual or threatened haemorrhage. Br Med J 1893; 2: 2235.
  • 3
    Lee RI, White PD. A clinical study of the coagulation time of blood. Am J Med Sci 1913; 145: 495503.
  • 4
    Jaques LB, Fidlar E, Feldsted ET, MacDonald AG. Silicones and blood coagulation. Can Med Assoc J 1946; 55: 2631.
  • 5
    Quick AJ, Honorato CR, Stefanini M. The value and the limitations of the coagulation time in the study of the hemorrhagic diseases. Blood 1948; 3: 11209.
  • 6
    Brinkhous KM, Langdell RD, Penick GD, Graham JB, Wagner RH. Newer approaches to the study of hemophilia and hemophilioid states. J Am Med Assoc 1954; 154: 4816.
  • 7
    Nichols TC, Dillow AM, Franck HWG, Merricks EP, Raymer RA, Bellinger DA, Arruda VR, High KA. Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency. ILAR J 2009; 50: 14467.
  • 8
    Herzog RW, Fields PA, Arruda VR, Brubaker JO, Armstrong E, McClintock D, Bellinger DA, Couto LB, Nichols TC, High KA. Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy. Hum Gene Ther 2002; 13: 128191.
  • 9
    Russell KE, Olsen EH, Raymer RA, Merricks EP, Bellinger DA, Read MS, Rup BJ, Keith JC Jr, McCarthy KP, Schaub RG, Nichols TC. Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogs. Blood 2003; 102: 43938.
  • 10
    Nichols TC, Raymer RA, Franck HW, Merricks EP, Bellinger DA, DeFriess N, Margaritis P, Arruda VR, Kay MA, High KA. Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B. Haemophilia 2010; 16 (Suppl. 3): 1923.
  • 11
    Hoffman M, Harger A, Lenkowski A, Hedner U, Roberts HR, Monroe DM. Cutaneous wound healing is impaired in hemophilia B. Blood 2006; 108: 305360.
  • 12
    Heimark RL, Schwartz SM. Binding of coagulation factors IX and X to the endothelial cell surface. Biochem Biophys Res Commun 1983; 111: 72331.
  • 13
    Stern DM, Knitter G, Kisiel W, Nawroth PP. In vivo evidence of intravascular binding sites for coagulation factor IX. Br J Haematol 1987; 66: 22732.
  • 14
    Wolberg AS, Stafford DW, Erie DA. Human factor IX binds to specific sites on the collagenous domain of collagen IV. J Biol Chem 1997; 272: 1671720.
  • 15
    Cheung WF, van den Born J, Kuhn K, Kjellen L, Hudson BG, Stafford DW. Identification of the endothelial cell binding site for factor IX. Proc Natl Acad Sci U S A 1996; 93: 1106873.
  • 16
    Schuettrumpf J, Herzog RW, Schlachterman A, Kaufhold A, Stafford DW, Arruda VR. Factor IX variants improve gene therapy efficacy for hemophilia B. Blood 2005; 105: 231623.
  • 17
    Brinkhous KM, Sigman JL, Read MS, Stewart PF, McCarthy KP, Timony GA, Leppanen SD, Rup BJ, Keith JC Jr, Garzone PD, Schaub RG. Recombinant human factor IX: replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B. Blood 1996; 88: 260310.
  • 18
    Goldsmith JC, Chung KS, Roberts HR. A simple assay for human factor IX: use of canine hemophilia B plasma as substrate. Thromb Res 1978; 12: 497502.
  • 19
    Wagenvoord R, Hendrix H, Tran T, Hemker HC. Development of a sensitive and rapid chromogenic factor IX assay for clinical use. Haemostasis 1990; 20: 27688.
  • 20
    Sugahara Y, Catalfamo J, Brooks M, Hitomi E, Bajaj SP, Kurachi K. Isolation and characterization of canine factor IX. Thromb Haemost 1996; 75: 4505.
  • 21
    Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 1993; 262: 1179.